What are Semaglutide and Tirzepatide?
If you’re an overweight adult suffering from being overweight or obese, you most likely have tried the typical OTC weight-loss pills on your journey to lose weight and keep it off. But the scientific and clinical facts are that many of those “weight-loss supplements” aren’t able to stimulate the necessary hormones needed to continuously control your appetite and promote fat loss. Moreover, many of them contain unknown additives that can cause harm to your body and seriously affect your health.
At Beso Semaglutide Weight Loss Clinic in Phoenix, AZ, we run an extensive Hormone optimization program that effectively helps patients with their weight management journey, however, we have found that none of the medications are more safe and potent as the glucagon-like peptide (GLP1) agonist – Semaglutide.
Known as a GLP-1 receptor agonist, semaglutide improves the secretion of glucagon and insulin, which results in a reduction of blood sugar levels and the promotion of weight loss. Semaglutide can also make you feel full after eating small portions and effectively suppress your appetite as it slow downs the gastrointestinal motility responsible for digestion.
Based on your medical history, our providers may prescribe either one of the two types of Semaglutide for weight loss: Wegovy or Ozempic. Although both Semaglutide drugs are FDA-cleared for weight loss, each one was designed to serve very different purposes. Ozempic is geared more towards Type 2 diabetics to help control their insulin and blood sugar levels and make it easier to lose weight. Whereas Wegovy is specifically designed for overweight and obese patients to help them lose weight and avoid developing more severe medical complications such as diabetes. In either case, both medications are revolutionary and our providers can help you decide the option for you.
In addition to semaglutide injections, we have had much success with newly FDA-approved for Type 2 Diabetes – Tirzepatide. Although its designation for the treatment of adults with obesity or overweight has not been officially approved, most patients are satisfied with the weight loss side benefits. It works similarly to the semaglutide family, but it contains a GIP receptor agonist in addition to a GLP-1 receptor agonist. Thus imitating not one, but two unique incretin hormones produced by the human body.
How Much Weight Can You Lose?
Every individual case is inherently different. Your weight loss results may vary depending on your body’s response, lifestyle changes and progress through treatment. However, in clinical studies, over 50% of patients who used Semaglutide injections have typically been shown to lose up to 10% of their body fat, compared to patients who only lost 5% of their weight after using other weight loss medications. Obese patients with a BMI of 38 saw a 12.4% reduction in total body fat and average weight loss of 33 pounds after combining Wegovy with their diet and exercise after a year of treatment.
At Beso, we go a long way to dispel one of the common misconceptions about medical weight loss being a replacement for living a healthy lifestyle. It is not. We help our patients incorporate physical activity and healthy eating habits into their life. In order to see the greatest short-term and long-term results, you must dedicate yourself to incorporating physical activity into your week and healthy eating habits for better healthspan.
How can Beso Wellness and Beauty help?
Beso Wellness and Beauty offers consultations for anyone looking into their medical weight loss options. We work together with you to develop a medical weight loss plan that is safe and effective for you. All patients always work directly with one of our providers to ensure patient safety and confidentiality. Schedule your consultation today!
FDA Disclaimer
The information contained herein is not intended to diagnose, treat, cure or prevent any disease. All information presented on this website is intended for informational use only and not for the purpose of rendering medical advice. Some of the statements made on this website have not been evaluated by the FDA.
RELATED PROCEDURES
MIC Injections
